OClawVPS.com
Wellington Partners
Edit

Wellington Partners

https://www.wellington-partners.com
Last activity: 28.02.2026
Active
Invests in categories: TechnologyDataMedTechHealthTechPlatformProductITAppServiceMusic
Wellington Partners is one of the most successful pan-European venture capital firms. With funds totalling over € 800 million, we have invested throughout Europe in companies that have the potential to become real market leaders for more than 15 years.

We are committed to providing outstanding entrepreneurs with the necessary resources to fund their strategies. We typically lead financing rounds ranging from € 0.5 million to € 20 million. Depending on the maturity of the company, our own commitment can go as high as € 15 million.

Providing funding is only one part of our business. After funding, the entrepreneurs we back have access to the advice and guidance of our complete team and our entire global network. Our investment professionals operate out of four offices, located in London, Munich, Zurich and Palo Alto. The pan-European and transatlantic makeup of our organisation enables us to support our portfolio in expanding globally.

To date, Wellington Partners has invested in more than 100 companies throughout Europe. We have been a part of great successes as well as dismal failures. In our view, success has always been the result of a great idea executed by a great team with strong leadership and commitment; plus an enormous amount of hard work and an ounce of luck, the good fortune to be in the right place at right time.
Likes
1.33K
Portfolio
93
Persons
14
Mentions
147
Location: Germany, Bavaria, Munich
Employees: 11-50
Founded date: 1998
Investment Type: Venture Capital
Investment Stage: Series A; Series C

Portfolio 93

DateNameWebsiteTotal RaisedLocation
24.02.2026nyra healt...nyra.health$28.34MAustria
08.08.2025SNIPR BIOM...sniprbiome.com$90.93MDenmark
11.07.2025NUCLIDIUM ...nuclidium.com$101.75MSwitzerlan...
16.03.2023Seamless T...seamlesstx.com$12.5MGermany, S...
25.02.2021Creative B...creativeballoons.de$18.25MGermany, B...
28.01.2021SIRS Thera...sirs-therapeutics.com--
09.01.2021ONWARDonwd.com$266.8MNetherland...
22.12.2020Minervax A...minervax.com$196.51MDenmark, C...
28.10.2020Sidekick H...sidekickhealth.com$76.5MSweden, Go...
07.05.2019Confo Ther...confotherapeutics.com$106.07MBelgium
Show more

Persons 14

DateFirst NameLast NameTitleLinkedInLocation
-OlenaIonkinaFinance Ma...-
-Dr.Johannes F...Managing P...linkedin.c...-
-CorneliaHuberFinance Ma...-
-Dr.Varun Gupt...Partnerlinkedin.c...-
-KaiWohlberedtAssociatelinkedin.c...-
-SabineKannegiess...Partner-
-HélèneVERGERExecutive ...linkedin.c...-
-Dr.Lisa Garte...Managerlinkedin.c...-
-EmericNouailhacAssociatelinkedin.c...-
-ErichSchlickGeneral Pa...linkedin.c...-
Show more

Mentions in press and media 147

DateTitleDescription
28.02.2026+++ Tytan +++ nyra.health +++ FLEXOO +++ Oska +++ Secfix +++ Avelios Medical +++Was gibt’s Neues? In unserem #StartupTicker-Wochenrückblick liefern wir einen schnellen Überblick darüber, was in der deutschsprachigen Startup-Szene zuletzt wirklich wichtig war! STARTUPLAND: SAVE THE DATE The next unicorn? You’ll meet it ...
26.02.2026European Startups Secure Major Funding, AI Dominates, US Expansion AcceleratesEuropean startups attract significant capital. HealthTech leads with nyra.health's €20 million for AI-powered neurological therapy. AI transforms wholesale via Plato, enterprise with VoiceLine, and model training through Rapidata. Strategic...
24.02.2026Nyra Health: €20 Million Series A Raised For AI-Based Neurotherapy Platform ExpansionVienna-based digital health company Nyra Health has raised €20 million in Series A funding to expand its AI-powered neurotherapy platform internationally and accelerate product development. The round was led by Armira Growth, with renewed p...
24.02.2026Amid €65 billion lost each year to stroke and dementia in Germany, nyra health secures €20 million to scale digital neurotherapyVienna-based nyra health, a provider of an AI-based platform for neurological therapy, announces the completion of a €20 million Series A financing round to further expand its technology platform in the DACH region, accelerate its expansion...
24.01.2026TRiCares: Up To €20 Million EIB Loan Secured To Advance Topaz Tricuspid Valve Replacement TrialsTRiCares SAS, a privately held medtech company developing a minimally invasive treatment for tricuspid regurgitation, said it has signed a loan agreement for up to €20 million in non-dilutive financing with the European Investment Bank, the...
22.10.2025EQT Life Sciences’ ImCheck Therapeutics to be acquired by Ipsen in a transaction valued at up to EUR 1 billionEQT Life Sciences’ ImCheck Therapeutics to be acquired by Ipsen in a transaction valued at up to EUR 1 billion Wed, Oct 22, 2025 09:20 CET Report this content Ipsen and ImCheck Therapeutics have entered into a definitive share purchase agre...
18.09.2025Capital meets care: 10 venture capital firms transforming healthcare across EuropeVenture capital remains one of the cornerstones of Europe’s innovation landscape, fuelling the growth of startups across every sector. In our last list, we spotlighted 15 VC firms focused on sustainability, underlining how investors are sha...
08.08.2025SNIPR BIOME Secures €35 Million to Revolutionize CRISPR-MedicineCopenhagen's SNIPR BIOME clinched €35 million in Series B funding. This significant capital injection drives microbial CRISPR-medicine innovation. Funds target critical health challenges: developing CRISPR-Cas therapy for severe airway infe...
08.08.2025Danish BioTech scale-up SNIPR Biome raises €35 million to target antimicrobial resistance in diseases like cancerCopenhagen-based SNIPR Biome, a BioTech company innovating the development of microbial CRISPR-medicine, announced the close of a €35 million Series B raise to advance CRISPR-based therapies for cystic fibrosis airway infections, combat ant...
07.08.2025SNIPR BIOME Raises EUR 35M in Series B FundingSNIPR BIOME, a Copenhagen, Denmark-based company improving the development of microbial CRISPR-medicine, raised EUR 35M in Series B funding. Backers included Cystic Fibrosis Foundation and the German Federal Agency for Breakthrough Innovati...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In